Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Spring Mountain Capital
AddedFeb 13, 2024
UpdatedJun 28, 2026
Spring Mountain Capital

Spring Mountain Capital

Operating

Spring Mountain Capital, LP: A NY-based private investment firm specializing in asset management and alternative investing.

Location
New York City, NY, US
Founded
2001
Firm
Compare
Portfolio
Employees
Website

Investments

xCures
xCures
Series B

Total Raised

$84M

Rounds

10

Series B$46MJune 2026
showd.me
showd.me

Total Raised

$1.5M

Rounds

2

Series ASeptember 2023
Recess
Recess

Total Raised

$11.4M

Rounds

3

Series A$5MNovember 2022
Vergent Bioscience
Vergent Bioscience

Total Raised

$34.4M

Rounds

3

Series B$21.5MOctober 2022
Series A$11.9MJune 2018
Genomenon
Genomenon

Total Raised

$32.8M

Rounds

8

Series B$20MMarch 2022
Everwash
Everwash

Total Raised

$11M

Rounds

2

Series B$6MMarch 2022
Eyrus
Eyrus
Series A

Total Raised

$14.5M

Rounds

6

Series A$12MFebruary 2022
Koneksa Health
Koneksa Health

Total Raised

$70.6M

Rounds

6

Series C$45MFebruary 2022
Series B$16MSeptember 2020
Ankyra
Ankyra

Total Raised

$59.5M

Rounds

2

Series B$45MNovember 2021
Aware
Aware

Total Raised

$87.1M

Rounds

8

Series C$60MOctober 2021
Series B$12MDecember 2020
Lessonbee
Lessonbee
Seed

Total Raised

$4.2M

Rounds

6

Seed$1.5MSeptember 2021
Allyx Therapeutics
Allyx Therapeutics

Total Raised

$10.1M

Rounds

4

Series Unknown$7.6MJune 2021
Maven Clinic
Maven Clinic

Total Raised

$292.1M

Rounds

7

Series C$52MFebruary 2020
Series B$27MSeptember 2018
Series A$10.8MJuly 2017
Keen Decision Systems
Keen Decision Systems

Total Raised

$17.9M

Rounds

4

Series A$4.6MApril 2019
ReNetX Bio
ReNetX Bio

Total Raised

$9.8M

Rounds

3

Series AMay 2018
Prevalent
Prevalent

Total Raised

$82.2M

Rounds

4

Series B$8MJanuary 2016
Hμrel
Hμrel

Total Raised

$9.2M

Rounds

1

Series A$9.2MApril 2013
Perquest
Perquest

Total Raised

$20.7M

Rounds

2

Series B$17.3MJuly 2007